Amphastar Pharmaceuticals
AMPH
#5766
Rank
C$1.81 B
Marketcap
C$42.57
Share price
2.10%
Change (1 day)
17.54%
Change (1 year)

Earnings for Amphastar Pharmaceuticals (AMPH)

Earnings in 2026 (TTM): C$0.17 Billion

According to Amphastar Pharmaceuticals's latest financial reports the company's current earnings are C$0.73 Billion. In 2025 the company made an earning of C$0.21 Billion a decrease over its 2024 earnings that were of C$0.31 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Amphastar Pharmaceuticals from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.17 B-16.32%
2025 C$0.21 B-32.26%
2024 C$0.31 B10.88%
2023 C$0.28 B68.4%
2022 C$0.16 B38.65%
2021 C$0.12 B1596.75%
2020 C$7.18 M-91.7%
2019 C$86.47 M-723.23%
2018 -C$13.88 Million-516.29%
2017 C$3.33 M-85.44%
2016 C$22.88 M-270.31%
2015 -C$13.44 Million-46.53%
2014 -C$25.14 Million-196.44%
2013 C$26.05 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Tonix Pharmaceuticals
TNXP
-C$0.24 Billion-226.72%๐Ÿ‡บ๐Ÿ‡ธ USA
SCYNEXIS
SCYX
-C$14.67 Million-107.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Marinus Pharmaceuticals
MRNS
-C$0.21 Billion-209.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
-C$21.54 Million-111.73%๐Ÿ‡บ๐Ÿ‡ธ USA